Valuation: Eckert & Ziegler SE

Market Cap 834M 966M 785M 713M 1.34B 92.54B 1.36B 9.21B 3.61B 46.28B 3.63B 3.55B 154B P/E 2026 *
16x
P/E 2027 * 15.1x
Enterprise Value 718M 831M 676M 614M 1.15B 79.66B 1.17B 7.92B 3.11B 39.84B 3.12B 3.05B 133B EV / Sales 2026 *
2.25x
EV / Sales 2027 * 2.08x
Free-Float
67.36%
Yield 2026 *
1.46%
Yield 2027 * 1.5%
1 day-0.48%
1 week-6.76%
Current month-6.63%
1 month-7.84%
3 months-12.31%
6 months-14.02%
Current year-15.77%
1 week 12.82
Extreme 12.82
13.8
1 month 12.82
Extreme 12.82
14.18
Current year 12.82
Extreme 12.82
16.82
1 year 12.82
Extreme 12.82
18.75
3 years 9.67
Extreme 9.666666
23.07
5 years 9.67
Extreme 9.666666
46.92
10 years 1.73
Extreme 1.728749
46.92
Manager TitleAgeSince
Chief Executive Officer 59 06/06/2023
Chief Tech/Sci/R&D Officer - 31/12/2024
Chief Operating Officer 59 31/12/2024
Director TitleAgeSince
Chairman 57 06/06/2023
Director/Board Member 66 31/12/2013
Director/Board Member 58 31/12/2016
Change 5-day change 1-year change 3-year change Capi.($)
-0.48%-6.76% - - 966M
+0.42%-2.71%+16.55%-33.99% 16.5B
-2.03%-2.16%-27.05%+102.54% 1.72B
+0.19%-3.05%-25.53%+25.91% 966M
-7.89%-4.00%-47.99%-81.92% 921M
0.00%-0.65%+67.36%-7.38% 778M
-1.89%+0.35%-39.37%-48.32% 680M
-3.67%+2.99%-40.72%-39.57% 613M
-0.49%+6.36%-42.02%-36.15% 444M
-1.08%+0.70%+60.77%+43.79% 417M
Average -1.69%-1.34%-8.67%-8.34% 2.56B
Weighted average by Cap. -0.35%-3.29%+7.16%-21.51%

Financials

2026 *2027 *
Net sales 319M 369M 300M 272M 513M 35.35B 520M 3.52B 1.38B 17.68B 1.39B 1.36B 58.89B 340M 394M 320M 291M 548M 37.77B 556M 3.76B 1.47B 18.89B 1.48B 1.45B 62.92B
Net income 51.68M 59.84M 48.62M 44.19M 83.12M 5.73B 84.34M 570M 224M 2.87B 225M 220M 9.55B 53.08M 61.46M 49.95M 45.39M 85.38M 5.89B 86.63M 586M 230M 2.95B 231M 226M 9.81B
Net Debt -116M -134M -109M -99.28M -187M -12.88B -189M -1.28B -502M -6.44B -505M -494M -21.46B -126M -145M -118M -107M -202M -13.92B -205M -1.39B -543M -6.96B -546M -534M -23.19B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,105
Date Price Change Volume
19/08/26 12.82 -4.47% 0
18/08/26 €13.39 -1.33% 164
17/08/26 €13.57 -0.37% 125
14/08/26 €13.62 +0.15% 4,040
13/08/26 €13.60 -1.09% 1,249
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.33EUR
Average target price
21.60EUR
Spread / Average Target
+62.04%

Annual profits - Rate of surprise